Re: Advertisement for desmopressin (DDAVP spray).
作者信息
McGrath P
机构信息
Department of Psychology, Clinical Psychology Program, Dalhousie University, Halifax, Nova Scotia.
出版信息
Paediatr Child Health. 1999 Oct;4(7):461. doi: 10.1093/pch/4.7.461.
Abstract
摘要
相似文献
1
Re: Advertisement for desmopressin (DDAVP spray).关于：去氨加压素（弥凝喷雾剂）广告。
Paediatr Child Health. 1999 Oct;4(7):461. doi: 10.1093/pch/4.7.461.
2
Nasal spray desmopressin (DDAVP) for mild hemophilia A and von Willebrand disease.用于轻度甲型血友病和血管性血友病的鼻腔喷雾去氨加压素（DDAVP）。
Ann Intern Med. 1991 Apr 1;114(7):563-8. doi: 10.7326/0003-4819-114-7-563.
3
Intranasal and intravenous administration of desmopressin: effect on F VIII/vWF, pharmacokinetics and reproducibility.去氨加压素的鼻内和静脉给药：对F VIII/vWF、药代动力学及重现性的影响
Thromb Haemost. 1987 Dec 18;58(4):1033-6.
4
High-dose DDAVP intranasal spray (Stimate) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia A.高剂量去氨加压素鼻喷雾剂（施他宁）用于预防和治疗轻度甲型血友病、轻度或中度1型血管性血友病患者以及甲型血友病有症状携带者的出血。
Haemophilia. 2001 May;7(3):258-66. doi: 10.1046/j.1365-2516.2001.00500.x.
5
Renal concentrating capacity test by desmopressin in children: intranasal or intravenous route?去氨加压素用于儿童的肾脏浓缩功能试验：经鼻还是静脉途径？
Am J Nephrol. 1993;13(2):129-31. doi: 10.1159/000168602.
6
DDAVP nasal spray for treatment of menorrhagia in women with inherited bleeding disorders: a randomized placebo-controlled crossover study.去氨加压素鼻喷雾剂治疗遗传性出血性疾病女性月经过多：一项随机安慰剂对照交叉研究。
Haemophilia. 2002 Nov;8(6):787-93. doi: 10.1046/j.1365-2516.2002.00678.x.
7
Intranasal desmopressin as an adjunct to risperidone for negative symptoms of schizophrenia: a randomized, double-blind, placebo-controlled, clinical trial.鼻腔给予去氨加压素作为利培酮辅助治疗精神分裂症阴性症状的随机、双盲、安慰剂对照临床试验。
Eur Neuropsychopharmacol. 2014 Jun;24(6):846-55. doi: 10.1016/j.euroneuro.2014.02.001. Epub 2014 Feb 25.
8
Intranasal desmopressin (DDAVP) by spray in mild hemophilia A and von Willebrand's disease type I.喷雾型鼻内去氨加压素（DDAVP）用于轻度甲型血友病和Ⅰ型血管性血友病。
Blut. 1990 Mar;60(3):187-91. doi: 10.1007/BF01720274.
9
[Clinical evaluation of 2 new formulations of desmopressin (DDAVP), nasal spray and tablets, in the therapy of diabetes insipidus].
Minerva Endocrinol. 1989 Oct-Dec;14(4):227-32.
10
Oral contraceptives and DDAVP nasal spray: patterns of use in managing vWD-associated menorrhagia: a single-institution study.口服避孕药与去氨加压素鼻腔喷雾剂：治疗血管性血友病相关性月经过多的使用模式：一项单机构研究
J Pediatr Hematol Oncol. 2005 Jul;27(7):357-63. doi: 10.1097/01.mph.0000173175.95152.95.
本文引用的文献
1
Desmopressin treatment: current status.去氨加压素治疗：现状
Scand J Urol Nephrol Suppl. 1999;202:70-2. doi: 10.1080/00365599950510274.
2
Long-term treatment with desmopressin in children with primary monosymptomatic nocturnal enuresis: an open multicentre study. Swedish Enuresis Trial (SWEET) Group.去氨加压素对原发性单症状性夜间遗尿症儿童的长期治疗：一项开放性多中心研究。瑞典遗尿症试验（SWEET）组。
Br J Urol. 1998 Nov;82(5):704-9. doi: 10.1046/j.1464-410x.1998.00826.x.
3
SWEET, the Swedish Enuresis Trial.
Scand J Urol Nephrol Suppl. 1995;173:89-92; discussion 93.
4
Nocturnal enuresis: experience with long-term use of intranasally administered desmopressin.夜间遗尿症：长期鼻内使用去氨加压素的经验
J Pediatr. 1989 Apr;114(4 Pt 2):723-6. doi: 10.1016/s0022-3476(89)80888-1.
Zotero 插件